{"id":"idanpramine","rwe":[],"tags":[{"label":"idanpramine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"A03AX06","category":"atc"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["idanpramine","idanpramine hydrochloride","idanpramine sulfate","idanpramine HCl"],"offLabel":[],"synonyms":["idanpramine","idanpramine hydrochloride","idanpramine sulfate","idanpramine HCl"],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"idanpramine","explanation":"Imagine your brain is a complex computer, and idanpramine is a software update that helps fix problems with how the computer processes information. By interacting with a specific part of the brain, idanpramine may help improve mood or other symptoms, but more research is needed to confirm this theory.","oneSentence":"Idanpramine is thought to work by interacting with a specific target in the body, although the exact nature of this interaction is not well understood.","technicalDetail":"Idanpramine's mechanism of action is not well-characterized, but it is believed to involve modulation of a specific molecular target, potentially influencing neurotransmitter release or receptor activity."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4574","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=idanpramine","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:59:51.383805","biosimilars":[],"competitors":[{"drugName":"isometheptene","drugSlug":"isometheptene","fdaApproval":"","relationship":"same-class"}],"genericName":"idanpramine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"isometheptene","brandName":"isometheptene","genericName":"isometheptene","approvalYear":"","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"8WIO2013UA","CHEBI":"CHEBI:81300","UMLSCUI":"C3652682","ChEMBL_ID":"CHEMBL3707301","DRUGBANK_ID":"DB13276","PUBCHEM_CID":"58521","SECONDARY_CAS_RN":"25466-21-1"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Neuroscience"],"atcClassification":{"source":"DrugCentral","atcCode":"A03AX06","allCodes":["A03AX06"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"idanpramine","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Idanpramine is a small molecule drug used for functional gastrointestinal disorders. It acts as an antimuscarinic agent.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}